89284-38-8

Usage

Uses

Used in Food Industry:
3,5-Dichloro-2-Methylpyrazine is used as a flavoring agent for adding a nutty and roasted flavor to products such as coffee, cocoa, and bread. Its ability to enhance the taste and aroma of these food items makes it a valuable ingredient in the culinary world.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 3,5-Dichloro-2-Methylpyrazine serves as an intermediate in the synthesis of various drugs. Its chemical structure allows for the development of new medicinal compounds, contributing to the advancement of pharmaceutical research and drug discovery.
Used in Agricultural Industry:
Similarly, in agriculture, 3,5-Dichloro-2-Methylpyrazine is utilized as an intermediate in the production of agrochemicals. Its role in the synthesis of pesticides and other agricultural chemicals helps improve crop protection and yield.
Safety Considerations:
3,5-Dichloro-2-Methylpyrazine is considered to be a relatively low-toxicity chemical, with no known significant health hazards associated with its use in regulated quantities. However, it is essential to handle 3,5-Dichloro-2-Methylpyrazine with caution and adhere to proper safety protocols to minimize any potential risks.

Upstream product

• 4774-14-5 2,6-dichloropyrazine 
• 74-88-4 methyl iodide 

Downstream Products

• 1430460-55-1 N-benzyl-6-chloro-3-methylpyrazin-2-amine 
• 1430460-76-6 N-benzyl-6-chloro-5-methylpyrazin-2-amine 

Relevant academic research and scientific papers

BIARYL DERIVATIVE AS GPR120 AGONIST

The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

Studies on the regioselective nucleophilic aromatic substitution (S NAr) reaction of 2-substituted 3,5-dichloropyrazines

Differences in regioselectivity were observed during the SNAr reaction of amines with unsymmetrical 3,5-dichloropyrazines. This study revealed that when the 2-position of the pyrazine was occupied with an electron-withdrawing group (EWG), nucle

6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS

The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as CHK-1 inhibitors.

THERAPEUTIC COMPOUNDS

The present invention relates to pyrazine substituted pyrrolopyridines which are inhibitors of JAK kinases (JAKl, JAK2, JAK3 and/or TYK2) and/or PDKl and are thus useful for the treatment of myeloproliferative disorders or cancer.

PYRAZINE-BASED TUBULIN INHIBITORS

A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described

Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands

Provided herein are novel heteroaromatic substituted cyclopropanes of the Formula (I): as well as compositions, including pharmaceutical compositions, containing the same, and the use thereof in the treatment of various neurological and psychological diso